- Home
- TAK vs CHTR Comparison
TAK vs CHTR Comparison
Compare TAK & CHTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- CHTR
- Stock Information
- Founded
- TAK 1781
- CHTR 1993
- Country
- TAK Japan
- CHTR United States
- Employees
- TAK N/A
- CHTR N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- CHTR Cable & Other Pay Television Services
- Sector
- TAK Health Care
- CHTR Telecommunications
- Exchange
- TAK Nasdaq
- CHTR Nasdaq
- Market Cap
- TAK 42.2B
- CHTR 50.5B
- IPO Year
- TAK N/A
- CHTR 1999
- Fundamental
- Price
- TAK $14.87
- CHTR $368.53
- Analyst Decision
- TAK
- CHTR Hold
- Analyst Count
- TAK 0
- CHTR 18
- Target Price
- TAK N/A
- CHTR $387.88
- AVG Volume (30 Days)
- TAK 1.5M
- CHTR 1.4M
- Earning Date
- TAK 05-08-2025
- CHTR 04-25-2025
- Dividend Yield
- TAK 3.96%
- CHTR N/A
- EPS Growth
- TAK 15.39
- CHTR 16.61
- EPS
- TAK 0.83
- CHTR 34.97
- Revenue
- TAK $29,124,927,177.00
- CHTR $55,085,000,000.00
- Revenue This Year
- TAK $8.53
- CHTR $2.14
- Revenue Next Year
- TAK N/A
- CHTR $1.50
- P/E Ratio
- TAK $34.06
- CHTR $10.55
- Revenue Growth
- TAK 9.83
- CHTR 0.88
- 52 Week Low
- TAK $12.58
- CHTR $236.08
- 52 Week High
- TAK $15.31
- CHTR $415.27
- Technical
- Relative Strength Index (RSI)
- TAK 53.68
- CHTR 52.61
- Support Level
- TAK $14.90
- CHTR $338.54
- Resistance Level
- TAK $15.17
- CHTR $388.02
- Average True Range (ATR)
- TAK 0.17
- CHTR 10.27
- MACD
- TAK -0.07
- CHTR 1.16
- Stochastic Oscillator
- TAK 21.43
- CHTR 60.61
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About CHTR Charter Communications Inc. New
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 57 million US homes and businesses, around 35% of the country. Across this footprint, Charter serves 29 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest US cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.